Express Scripts Takes Legal Action Against FTC Over Drug Pricing Allegations
Legal Action Initiated by Express Scripts
In a significant move, Express Scripts, a prominent pharmacy benefit manager (PBM), has filed a lawsuit against the FTC over claims made in its drug pricing report published in July 2024. The report, according to Express Scripts, is riddled with false and misleading claims regarding the PBM industry.
Claims of Inaccuracies
Express Scripts argues that the allegations presented by the FTC misrepresent the realities of the PBM market, accusing the agency of disseminating misleading information that could adversely affect their reputation. The lawsuit demands a full retraction of the report to rectify these purported inaccuracies.
Potential Implications
This lawsuit could have far-reaching implications, not just for Express Scripts but for the entire pharmaceutical industry, especially in terms of how regulatory agencies prepare and present their findings.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.